MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clml.2025.07.004

Медицинская библиотека · Clinical lymphoma, myeloma & leukemia · 2025

Cognitive Performance in Patients With Multiple Myeloma Treated With an Autologous Stem Cell Transplant: Results of the Brilliant Study.

Rodriguez Cesar, Tam Melanie, Hurd David, Dressler Emily V, Krishnamurthy Sarada, Vaidya Rakhee, Smith Sydney, Rapp Stephen R, Wallander Michelle L, Duckworth Katie E

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Patients with newly diagnosed multiple myeloma undergo induction chemotherapy, followed by high-dose chemotherapy and autologous hematopoietic cell transplant (auto-HCT). The impact of auto-HCT on cognitive function is not well understood. We evaluated longitudinal changes in cognitive function after auto-HCT in patients with multiple myeloma.

PATIENTS AND

METHODS

Patients with newly diagnosed multiple myeloma who completed induction chemotherapy and underwent pre-transplant evaluation were enrolled prospectively. Patients completed the self-administered gerocognitive exam (SAGE) and specialist-administered Montreal cognitive assessment (MoCA) at 3 time points: pre-transplant (baseline), 100-days post-transplant, and 1-year post-transplant. Scores were reported as means and standard deviations. Paired t-tests evaluated longitudinal differences.

RESULTS

Thirty-eight (100%) participants completed the MoCA and SAGE at baseline and 100-days post-transplant, and nineteen (50%) participants completed both at 1-year post-transplant. The mean total MoCA score was 25.00 (SD = 3.05) at baseline, 25.87 (SD = 2.68) at 100-days post-transplant, and 26.00 (SD = 2.81) at 1-year post-transplant. The mean total SAGE score was 17.00 (SD = 3.89) at baseline, 17.76 (SD = 3.07) at 100-days post-transplant, and 18.18 (SD = 3.23) at 1-year post-transplant. At 100-days post-transplant, the mean change from baseline in MoCA score was 0.87 (SD = 3.16; P = .10) and the mean change in SAGE score was 0.76 (SD = 2.62; P = .08). Participants did not indicate a preference for self-administered versus provider-administered measures.

CONCLUSION

Our study shows that auto-HCT was not associated with cognitive decline on objective assessment. Cognitive assessment is feasible and acceptable, with good correlation between self-administered tests and those administered by trained specialists.

Для цитирования: Rodriguez Cesar, Tam Melanie, Hurd David, Dressler Emily V, Krishnamurthy Sarada, Vaidya Rakhee, Smith Sydney, Rapp Stephen R, Wallander Michelle L, Duckworth Katie E. Cognitive Performance in Patients With Multiple Myeloma Treated With an Autologous Stem Cell Transplant: Results of the Brilliant Study.. Clinical lymphoma, myeloma & leukemia. 2025. DOI: 10.1016/j.clml.2025.07.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.